ChrysCapital, Motilal Oswal lead $153 million secondary funding in Healthkart at $500 million valuation
Health supplements startup Healthkart's existing investor, A91 Partners, and Neo Group also participated in the round. ET first reported on the impending deal at Healthkart with ChrysCapital in April.